DaxibotulinumtoxinA for Injection for the Treatment of Plantar Fasciitis
NCT03825315
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
155
Enrollment
INDUSTRY
Sponsor class
Conditions
Plantar Fasciitis
Interventions
BIOLOGICAL:
DAXI 80 U
BIOLOGICAL:
DAXI 120 U
OTHER:
Placebo
Sponsor
Revance Therapeutics, Inc.